244 related articles for article (PubMed ID: 2468274)
1. Prostate-specific antigen (PSA) in the management of 500 prostatic patients.
Guillet J; Role C; Duc AT; François H
Am J Clin Oncol; 1988; 11 Suppl 2():S61-2. PubMed ID: 2468274
[TBL] [Abstract][Full Text] [Related]
2. Significance of PSA and PAP in patients with or without prostatic cancer.
Caty A; Gosselin P; Cazin JL; Dehaut JM; Adenis L
Am J Clin Oncol; 1988; 11 Suppl 2():S63-4. PubMed ID: 2468275
[TBL] [Abstract][Full Text] [Related]
3. Is prostate-specific antigen the most useful marker for screening in prostate cancer?
Delaere KP; Van Dieijen-Visser MP; Gijzen AH; Brombacher PJ
Am J Clin Oncol; 1988; 11 Suppl 2():S65-7. PubMed ID: 2468276
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
Daver A; Soret JY; Coblentz Y; Allain YM; Cellier P; Chauveau P
Am J Clin Oncol; 1988; 11 Suppl 2():S53-60. PubMed ID: 2468273
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancer.
Turkes A; Nott J; Turkes AO; Griffiths K
Am J Clin Oncol; 1988; 11 Suppl 2():S77-9. PubMed ID: 2468280
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prostate-specific antigen in prostate cancer.
Pons-Anicet D; Ramaioli A; Namer M; Krebs BP
Am J Clin Oncol; 1988; 11 Suppl 2():S71-4. PubMed ID: 2468278
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
van Dieijen-Visser MP; Hendriks MW; Delaere KP; Gijzen AH; Brombacher PJ
Clin Chim Acta; 1988 Sep; 177(1):77-80. PubMed ID: 2460272
[TBL] [Abstract][Full Text] [Related]
8. Clinical behaviour of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
Morote Robles J; Ruibal Morell A; De Torres Mateos JA; Soler Roselló A
Int J Biol Markers; 1989; 4(2):87-94. PubMed ID: 2475553
[TBL] [Abstract][Full Text] [Related]
9. Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
Fincker F; Sauvan R; Pasquier J
Am J Clin Oncol; 1988; 11 Suppl 2():S68-70. PubMed ID: 2468277
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen in prostatic cancer.
Baron JC; Peyret C; Leroy M; Teillac P; Najean Y; Le Duc A
Am J Clin Oncol; 1988; 11 Suppl 2():S75-6. PubMed ID: 2468279
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
Oesterling JE
J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Buamah PK; Johnson P; Skillen AW
Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
[TBL] [Abstract][Full Text] [Related]
15. A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
van Dieijen-Visser MP; Delaere KP; Gijzen AH; Brombacher PJ
Clin Chim Acta; 1988 May; 174(2):131-40. PubMed ID: 2454767
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
[TBL] [Abstract][Full Text] [Related]
17. Prostate specific antigen--a screening test for prostatic cancer?
Powell CS; Fielding AM; Rosser K; Ames AC; Vaughton KC
Br J Urol; 1989 Nov; 64(5):504-6. PubMed ID: 2482112
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
Seamonds B; Yang N; Anderson K; Whitaker B; Shaw LM; Bollinger JR
Urology; 1986 Dec; 28(6):472-9. PubMed ID: 2431533
[TBL] [Abstract][Full Text] [Related]
19. Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy.
De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F
Urol Oncol; 2015 Oct; 33(10):424.e17-23. PubMed ID: 26162485
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.
Dupont A; Cusan L; Gomez JL; Thibeault MM; Tremblay M; Labrie F
J Urol; 1991 Oct; 146(4):1064-7; discussion 1067-8. PubMed ID: 1716697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]